These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32459717)

  • 1. Flow Cytometry-based Absolute Blast Count on Day 8: Reliable, Fast, and Inexpensive Method.
    Aycicek A; Pasli Uysalol E; Tahtakesen TN; Ozdemir GN; Akici F; Bayram C
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):33. PubMed ID: 32459717
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrospinal fluid analysis by 8-color flow cytometry in children with acute lymphoblastic leukemia.
    Gabelli M; Disarò S; Scarparo P; Francescato S; Zangrando A; Valsecchi MG; Putti MC; Basso G; Buldini B
    Leuk Lymphoma; 2019 Nov; 60(11):2825-2828. PubMed ID: 31018745
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of short-course high-dose methylprednisolone on peripheral blood lymphocyte subsets in children with acute leukemia during remission induction treatment.
    Tunç B; Oner AF; Hiçsönmez G
    Leuk Res; 2003 Jan; 27(1):19-21. PubMed ID: 12479848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels.
    Mullighan CG; Jeha S; Pei D; Payne-Turner D; Coustan-Smith E; Roberts KG; Waanders E; Choi JK; Ma X; Raimondi SC; Fan Y; Yang W; Song G; Yang JJ; Inaba H; Downing JR; Leung WH; Bowman WP; Relling MV; Evans WE; Zhang J; Campana D; Pui CH
    Blood; 2015 Dec; 126(26):2896-9. PubMed ID: 26527677
    [No Abstract]   [Full Text] [Related]  

  • 5. Day 22 of induction therapy is important for minimal residual disease assessment by flow cytometry in childhood acute lymphoblastic leukemia.
    Xu XJ; Tang YM; Shen HQ; Song H; Yang SL; Shi SW; Xu WQ
    Leuk Res; 2012 Aug; 36(8):1022-7. PubMed ID: 22483330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of children with recurrent acute lymphoblastic leukemia].
    Sotnikova NI
    Pediatriia; 1989; (4):62-5. PubMed ID: 2734065
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse.
    von Stackelberg A; Seeger K; Henze G; Eckert C
    Leukemia; 2004 Oct; 18(10):1727-8; author reply 1728-9. PubMed ID: 15356653
    [No Abstract]   [Full Text] [Related]  

  • 8. Need for new thinking: Treatment of relapsed leukemia in children with Down syndrome.
    Rabin K; Izraeli S; Hijiya N; Hitzler J
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27644. PubMed ID: 30724029
    [No Abstract]   [Full Text] [Related]  

  • 9. Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000.
    Schumich A; Maurer-Granofszky M; Attarbaschi A; Pötschger U; Buldini B; Gaipa G; Karawajew L; Printz D; Ratei R; Conter V; Schrappe M; Mann G; Basso G; Dworzak MN;
    Pediatr Blood Cancer; 2019 May; 66(5):e27590. PubMed ID: 30561169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of day 14 blast percentage and the absolute blast index in bone marrow of children with acute lymphoblastic leukemia.
    Visser JH; Wessels G; Hesseling PB; Louw I; Oberholster E; Mansvelt EP
    Pediatr Hematol Oncol; 2001; 18(3):187-91. PubMed ID: 11293286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of adults with acute lymphoblastic leukemia treated with a pediatric-inspired therapy: a single institution experience.
    Ruiz-Delgado GJ; Macías-Gallardo J; Lutz-Presno JA; Montes-Montiel M; Ruiz-Argüelles GJ
    Leuk Lymphoma; 2011 Feb; 52(2):314-6. PubMed ID: 21054153
    [No Abstract]   [Full Text] [Related]  

  • 12. Profound abnormality of the B/T lymphocyte ratio during chemotherapy for pediatric acute lymphoblastic leukemia.
    Caver TE; Slobod KS; Flynn PM; Behm FG; Hudson MM; Turner EV; Webster RG; Boyett JM; Tassie TL; Pui CH; Hurwitz JL
    Leukemia; 1998 Apr; 12(4):619-22. PubMed ID: 9557622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anemia and recurrences in acute lymphoblastic leukemia in children after the treatment and the frequency of the erythroblasts with micronuclei].
    Rytwiński K; Sońta-Jakimczyk D; Konopacka M; Ciechanowska U
    Acta Haematol Pol; 1992; 23(2):95-9. PubMed ID: 1488866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of children with relapsed and refractory acute lymphoblastic leukemia with mitoxantrone, vincristine, pegaspargase, dexamethasone, and bortezomib.
    August KJ; Guest EM; Lewing K; Hays JA; Gamis AS
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28062. PubMed ID: 31724803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
    Ochocka M; Zelenay E
    Pediatr Pol; 1988 Nov; 63(11):716-22. PubMed ID: 3253658
    [No Abstract]   [Full Text] [Related]  

  • 17. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
    Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
    Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid profile during chemotherapy in children with acute lymphoblastic leukemia.
    Madan D; Aggarwal P; Jain A; Gupta V
    Indian J Cancer; 2021; 58(3):461-462. PubMed ID: 34380832
    [No Abstract]   [Full Text] [Related]  

  • 19. [Childhood leukemia from the perspective of 15 years of its intensive treatment].
    Radwańska U
    Pediatr Pol; 1988 Nov; 63(11):689-92. PubMed ID: 3253654
    [No Abstract]   [Full Text] [Related]  

  • 20. [Testicular recurrence of acute lymphoblastic leukemia in children treated by BFM 81 83 protocol. Report of the Polish Group for the Treatment of Leukemia and Other Lymphatic Diseases in Children].
    Koehler M; Bubała H; Daszkiewicz P; Newecka-Samól T; Rodziewicz B; Rytlewska M; Skrobowska A; Sońta-Jakimczyk D; Trendowska D
    Pol Tyg Lek; 1988 Dec; 43(50):1615-8. PubMed ID: 3256802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.